Mexico City: Pharmaceutical company Merck is nearing a roughly USD 6 billion all-cash deal to acquire biotech firm Terns Pharma, the Financial Times reported on Tuesday, citing people familiar with…
Bengaluru: The U.S. drugmaker Pfizer and France's Valneva said on Monday their experimental Lyme disease vaccine showed more than 70% efficacy in a late-stage trial.Pfizer said it had planned to…
Researchers have found in a new study that cardiovascular disease (CVD) is associated with a higher risk of developing nonmelanoma skin cancer (NMSC), with obesity and inflammation partially mediating this…
Metabolic-associated fatty liver disease (MASLD) impacts roughly 30% of people globally and has long lacked effective, targeted therapies. Now, researchers have uncovered a key genetic factor that worsens the condition.…
Researchers have found in a new study that adjunctive melatonin therapy significantly improves glycemic control in patients with type 2 diabetes mellitus (T2DM) and periodontitis. These findings suggest melatonin may…
Researchers have found in a small controlled study that a single 25 mg dose of amphetamine-dextroamphetamine (Adderall) in healthy individuals without ADHD led to increased blood pressure, heart rate, and…
USA: New research has revealed that chronic rhinosinusitis (CRS) is associated with an increased risk of developing asthma and future exacerbations. The presence of coexisting allergic rhinitis (AR) identifies a…
A new study published in the journal of BMC Surgery found that the incidence of Frey syndrome was similar across surgical techniques. However, monopolar cautery showed a trend toward a…
Eli Lilly and the "societal obligation" of GLP-1s, Merck's Terns Pharma purchase, and more biotech news in today's Readout newsletter.
Merck intends to buy Terns Pharmaceuticals, the developer of a promising leukemia treatment, for $6.7 billion